Go Deep
Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,699 | -3.6 | 1.99 | 0.13 | 1,145.66 |
| Oct 2026 | 20,962 | -3.3 | 1.84 | 0.13 | 1,055.82 |
| Oct 2026 | 20,919 | -3.7 | 1.86 | 0.13 | 1,070.21 |
| Oct 2026 | 21,189 | -3.1 | 1.71 | 0.13 | 979.35 |
| Oct 2026 | 20,965 | -3.1 | 1.72 | 0.13 | 987.99 |
| Oct 2026 | 20,803 | -3.3 | 1.82 | 0.13 | 1,041.08 |
| Oct 2026 | 19,985 | -3.3 | 1.83 | 0.13 | 1,047.02 |
| Oct 2026 | 20,108 | -3.2 | 1.77 | 0.13 | 1,012.81 |
Arcturus Therapeutics Holdings Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 880,000.0 | 610,000.0 | 3,081,000.0 | 14,153,000.0 |
| Net Profit | -23,785,000.0 | -26,964,000.0 | -29,079,000.0 | -13,448,000.0 |
| EPS | -0.8 | -0.9 | -1.0 | -0.5 |
Arcturus Therapeutics Holdings Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 67,221,000.0 | 138,389,000.0 | 157,748,000.0 | 205,755,000.0 | — |
| Net Profit | -65,783,000.0 | -80,941,000.0 | -29,725,000.0 | 9,349,000.0 | — |
| EPS | -2.4 | -3.0 | -1.0 | 0.3 | — |
Arcturus Therapeutics Holdings Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 271,148,000.0 | 344,069,000.0 | 429,402,000.0 | 450,387,000.0 | — |
| Total Liabilities | 57,163,000.0 | 103,091,000.0 | 150,889,000.0 | 180,075,000.0 | — |
| Total Equity | 213,985,000.0 | 240,978,000.0 | 278,513,000.0 | 270,312,000.0 | — |
Owes vs Owns
Arcturus Therapeutics Holdings Inc. owed $0.23 for every $1 it owned in Jun 2026, down from $0.40 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.21× | 0.30× | 0.35× | 0.40× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Arcturus Therapeutics Holdings Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 85.2%Receivables 2.1%Fixed assets (tangible) 10.3%Other assets 2.5%
How it's funded — Dec 2025
Short-term debt 1.6%Long-term debt 7.7%Payables 1.6%Other liabilities 10.3%Shareholders' equity 78.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 230.9 | 237.0 | 292.0 | 391.9 |
| Receivables | 5.6 | 4.0 | 32.1 | 2.8 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 27.8 | 36.2 | 40.9 | 45.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 6.9 | 66.9 | 64.4 | 10.8 |
| Liabilities & equity | ||||
| Short-term debt | 4.2 | 3.6 | 4.3 | 60.7 |
| Long-term debt | 20.8 | 25.0 | 25.9 | 30.2 |
| Payables | 4.2 | 7.2 | 5.3 | 7.4 |
| Other liabilities | 27.9 | 67.3 | 115.4 | 81.8 |
| Shareholders' equity | 214.0 | 241.0 | 278.5 | 270.3 |
| Net tangible assets | 214.0 | 241.0 | 278.5 | 270.3 |
Arcturus Therapeutics Holdings Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -74,271,000.0 | -59,747,000.0 | -18,099,000.0 | 31,993,000.0 | — |
| Investing Activities | -230,000.0 | -648,000.0 | -2,901,000.0 | -7,726,000.0 | — |
| Financing Activities | 13,382,000.0 | 5,418,000.0 | -24,087,000.0 | -2,859,000.0 | — |